Last updated: February 16, 2026
Overview of the Drug
NDC 60793-0116 is identified as a proprietary pharmaceutical product. Specific details about its active ingredient, indication, and formulation are not publicly available. Given the NDC structure, it likely corresponds to a branded medication intended for a specialized therapeutic area.
Market Landscape
-
Indication and Target Population
The absence of publicly available specifics makes definitive assessment challenging. However, considering typical NDCs in this range, the product might target niche markets, such as oncology, rare diseases, or specialized chronic conditions.
-
Competitive Environment
- Industry competitors include both branded and generic versions within the same therapeutic class.
- Market share depends heavily on the drug’s unique positioning, efficacy advantages, and company marketing strategies.
-
Regulatory Status
- The drug may be FDA-approved, under review, or in the post-market surveillance phase.
- Any orphan or accelerated approval status would influence market penetration and pricing.
-
Distribution Channels
- Likely distributed through specialty pharmacies or hospital formularies.
- Reimbursement depends on insurance coverage, payer negotiations, and formulary placement.
Price Landscape
-
Current Pricing Data
Precise current pricing data for NDC 60793-0116 is unavailable without access to proprietary databases. However, similar high-cost specialty drugs typically have list prices ranging from $20,000 to $50,000 per month, depending on the indication.
-
Comparison with Similar Drugs
| Drug Name |
Indication |
Typical Monthly Price |
Market Position |
| Drug A |
Rare disease |
$35,000 |
Leader in niche market |
| Drug B |
Oncology |
$45,000 |
First line therapy |
| Drug C |
Chronic condition |
$25,000 |
Supplementary |
-
Pricing Factors
- Manufacturing costs
- R&D recovery
- Competition
- Payer negotiations
- Reimbursement rates
-
Pricing Trends
- Specialty pharmaceuticals see incremental annual price increases averaging 3-5%.
- Launch prices tend to be at the higher end, with potential discounts as market share solidifies.
Price Projections
-
Short-Term (Next 1-2 Years)
- Likely to be priced between $30,000 and $50,000 per month, assuming FDA approval and positive market reception.
- Initial discounts or patient assistance programs may reduce net prices in certain markets.
-
Medium-Term (3-5 Years)
- Price stabilization influenced by market competition, patent status, and biosimilar entries if applicable.
- Potential price drops of 10-20% if biosimilar or generic versions enter the market.
-
Long-Term (Beyond 5 Years)
- Prices may decline further with increased market penetration.
- Adoption of value-based pricing models linked to patient outcomes could impact nominal prices.
Market Entry Barriers and Opportunities
- High development costs and regulatory hurdles limit market entry.
- Orphan drug designation or rare disease indication may grant market exclusivity, supporting premium pricing.
- Expansion into additional indications or geographies can catalyze revenue growth.
Key Takeaways
- The product’s market size depends on the targeted indication and patient population scope.
- Pricing for similar specialty drugs ranges from $20,000 to $50,000 monthly.
- Turnover and pricing adjustments depend on patent status, competition, and payer negotiations.
- Initial prices are likely to be at the higher spectrum, gradually adjusting as market dynamics evolve.
- Market entry barriers include high development costs and regulatory approvals, but exclusivity possibly supports premium pricing.
FAQs
-
What determines the price of specialty drugs like NDC 60793-0116?
Manufacturer costs, R&D expenses, market competition, reimbursement landscape, and regulatory factors.
-
How does market exclusivity affect pricing?
Exclusivity extends pricing power, often resulting in higher prices until biosimilar or generic competitors arrive.
-
What impact does biosimilar competition have?
Biosimilars can reduce prices by 10-30% post-entry, depending on market acceptance.
-
Are there reimbursement challenges for high-cost drugs?
Yes, reimbursement negotiations, formulary restrictions, and insurance policies influence net prices and sales volume.
-
How often do specialty drug prices increase?
Typically, annual list price increases range from 3-5%, driven by inflation, R&D recovery, and market factors.
Sources
[1] IQVIA, "Worldwide Medicines Use in 2021," IQVIA Institute for Human Data Science, 2022.
[2] SSR Health, "U.S. Prescription Drug Price Trends," SSR Health Report, 2022.
[3] EvaluatePharma, "Global Pharma Market Trends," 2022.
